Subvisible particulate matter is under increasing amounts of scrutiny in the field of parenteral and ophthalmic drug products. USP <1788> and <1788.3> explicitly recommend the use of flow imaging and ...
A revised version of the USP chapter on Subvisible Particulate Matter USP<1788> became official on 1 st May 2021. USP<1788> is meant to expand on the information given in the chapters <787>, <788> and ...
Biotherapeutics continue to revolutionize how clinicians treat many human diseases. Protein therapies using molecules like peptides and monoclonal antibodies have become well established in the clinic ...
Subvisible particulate testing is critical to assess the safety of medical devices, and particulate contamination should be minimized to avoid possible negative health consequences to the patient. A ...
Protein-based therapeutics have transformed treatments for numerous diseases, yet their production remains highly complex and cost-intensive [1][2],[3][4]. Downstream processing (DSP), including ...
Halo Labs is an innovator in drug product characterization and subvisible particle analysis providing unprecedented product quality insights to improve patient safety. Starting with the launch of its ...
Subvisible particulate testing is critical to assess the safety of medical devices, and particulate contamination should be minimized to avoid possible negative health consequences to the patient. A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results